UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group

European urology, 2009-06, Vol.55 (6), p.1269-1277

2009

Volltextzugriff (PDF)

Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group

European urology, 2014-08, Vol.66 (2), p.232-239

2014

Volltextzugriff (PDF)

ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

BMC cancer, 2009-10, Vol.9 (1), p.357-357, Article 357

2009

Volltextzugriff (PDF)

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines

Urology (Ridgewood, N.J.), 2009-10, Vol.74 (4), p.944-950

2009

Volltextzugriff (PDF)

PD27-10 EFFECTS OF PRIOR USE OF STATINS IN A PHASE 3 STUDY OF INTERMITTENT VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

The Journal of urology, 2014-04, Vol.191 (4), p.e768-e768

2014

Volltextzugriff (PDF)

Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice

Frontiers in oncology, 2024-01, Vol.13, p.1266369-1266369

2024

Volltextzugriff (PDF)

The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospital

International urology and nephrology, 2021, Vol.53 (1), p.41-47

2021

Volltextzugriff (PDF)

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

European urology, 2011-03, Vol.59 (3), p.438-446

2011

Volltextzugriff (PDF)

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

Molecular oncology, 2014-05, Vol.8 (3), p.753-765

2014

Volltextzugriff (PDF)

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European urology, 2010-05, Vol.57 (5), p.766-773

2010

Volltextzugriff (PDF)

PD27-02 EVALUATION OF 1045 PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PROSTATE CANCER TREATED WITH IAT OR MAB - SOUTH EUROPEAN UROONCOLOGICAL GROUP

The Journal of urology, 2014-04, Vol.191 (4), p.e764-e765

2014

Volltextzugriff (PDF)

PD27-10 EFFECTS OF PRIOR USE OF STATINS IN A PHASE 3 STUDY OF INTERMITTENT VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

The Journal of urology, 2014, Vol.191 (4), p.e768-e768

2014

Volltextzugriff (PDF)

776 POOLED ANALYSIS OF TWO PROTOCOLS OF INTERMITTENT HORMONAL THERAPY IN ADVANCED PROSTATIC CANCER

The Journal of urology, 2012-04, Vol.187 (4), p.e317-e317

2012

Volltextzugriff (PDF)

Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials

European urology, 2013-11, Vol.64 (5), p.722-730

2013

Volltextzugriff (PDF)

Re: Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer

European urology, 2021-02, Vol.79 (2), p.318-319

2021

Volltextzugriff (PDF)

Systemic humoral responses of non-muscle-invasive bladder cancer during BCG treatment: less is more

Journal of cancer metastasis and treatment, 2017-07, Vol.3 (7), p.116

2017

Volltextzugriff (PDF)

Legends in Urology

Canadian journal of urology, 2016-12, Vol.23 (6), p.8531

Calais da Silva, Fernando

2016

Volltextzugriff (PDF)

Is intermittent androgen‐deprivation therapy beneficial for patients with advanced prostate cancer?

BJU international, 2014-10, Vol.114 (4), p.476-483

2014

Volltextzugriff (PDF)

Tumor clone dynamics in lethal prostate cancer

European urology, 2017-01, Vol.71 (1), p.142-143

2017

Volltextzugriff (PDF)

(16) PEYRONIE’S DISEASE: MALE AND FEMALE PERSONAL EXPERIENCE

Journal of sexual medicine, 2023-07, Vol.20 (Supplement_4)

2023

Volltextzugriff (PDF)

Fracture of the penis – 10 year experience of a tertiary center

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S92-S92

2022

Volltextzugriff (PDF)

Fracture of the penis – 10 year experience of a tertiary center

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S27-S27

2022

Volltextzugriff (PDF)

Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

International journal of cancer, 2002-01, Vol.97 (2), p.237-244

2002

Volltextzugriff (PDF)

716 PHASE III STUDY OF INTERMITTENT MAB VS CONTINUOS MAB

The Journal of urology, 2011-04, Vol.185 (4), p.e288-e288

2011

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group

ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines

PD27-10 EFFECTS OF PRIOR USE OF STATINS IN A PHASE 3 STUDY OF INTERMITTENT VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice

The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospital

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

PD27-02 EVALUATION OF 1045 PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PROSTATE CANCER TREATED WITH IAT OR MAB - SOUTH EUROPEAN UROONCOLOGICAL GROUP

PD27-10 EFFECTS OF PRIOR USE OF STATINS IN A PHASE 3 STUDY OF INTERMITTENT VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

776 POOLED ANALYSIS OF TWO PROTOCOLS OF INTERMITTENT HORMONAL THERAPY IN ADVANCED PROSTATIC CANCER

Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials

Re: Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer

Systemic humoral responses of non-muscle-invasive bladder cancer during BCG treatment: less is more

Legends in Urology

Is intermittent androgen‐deprivation therapy beneficial for patients with advanced prostate cancer?

Tumor clone dynamics in lethal prostate cancer

(16) PEYRONIE’S DISEASE: MALE AND FEMALE PERSONAL EXPERIENCE

Fracture of the penis – 10 year experience of a tertiary center

Fracture of the penis – 10 year experience of a tertiary center

Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

716 PHASE III STUDY OF INTERMITTENT MAB VS CONTINUOS MAB

Suchergebnisse filtern